Clinical Trials Using Mogamulizumab
Review the clinical trials studying mogamulizumab on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-9 of
9
- Status: ActiveLocation: 9 locations
- Status: ActiveLocation: 3 locations
- Status: ActiveLocation: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
- Status: ActiveLocation: Stanford Cancer Institute Palo Alto, Palo Alto, California
- Status: ActiveLocation: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
- Status: ActiveLocation: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
- Status: ActiveLocation: Moffitt Cancer Center, Tampa, Florida
- Mogamulizumab for the Prevention of Adult T-Cell Leukemia/Lymphoma in High-Risk Patients with HTLV-1Status: ActiveLocation: 7 locations
- Status: ActiveLocation: 2 locations